SIP
BHC icon

Stoneridge Investment Partners’s Bausch Health BHC Stock Holding History

Stoneridge Investment Partners’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-96,122
Closed -$1.4M – 313
2016
Q4 		$1.4M Sell
96,122
-10,781
-10% -$198K 0.19% 146
2016
Q3 		$2.62M Sell
106,903
-31,734
-23% -$821K 0.38% 100
2016
Q2 		$2.79M Sell
138,637
-2,169
-2% -$61.4K 0.42% 79
2016
Q1 		$3.7M Buy
140,806
+66,046
+88% +$4.88M 0.54% 58
2015
Q4 		$7.6M Buy
+74,760
New +$8.4M 1.02% 25

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Stoneridge Investment Partners's BHC Position: Q1 2017 in Review

Stoneridge Investment Partners sold out of Bausch Health (BHC) in Q1 2017, closing a stake of 96,122 shares — an estimated $1.4M sold.

Stoneridge Investment Partners first reported a position in BHC in Q4 2015 and held it in 5 quarters. The position peaked at $7.6M in Q4 2015. 327 funds tracked by Wall St. Rank hold BHC as of Q1 2017.

  • Stoneridge Investment Partners reported no remaining Bausch Health position as of Q1 2017 after selling out during the quarter.
  • Stoneridge Investment Partners sold 96,122 Bausch Health shares in Q1 2017, an estimated $1.4M.
  • Stoneridge Investment Partners first reported a position in Bausch Health in Q4 2015 and held it in 5 quarters.
  • Stoneridge Investment Partners's Bausch Health position peaked at $7.6M in Q4 2015.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q1 2017.

Based on Stoneridge Investment Partners's 13F filing for Q1 2017, filed 1 May 2017.